Business Description
HCA Healthcare Inc
NAICS : 622110
SIC : 8062
ISIN : US40412C1018
Compare
Compare
Traded in other countries / regions
HCA.USA0J1R.UKH1CA34.BrazilHCA.Mexico2BH.Germany1HCA.Italy IPO Date
2011-03-10Description
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of June 2024, the firm owned and operated 188 hospitals, 123 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | -0.04 | |||||
| Debt-to-Equity | -20.57 | |||||
| Debt-to-EBITDA | 3.21 | |||||
| Interest Coverage | 5.19 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.58 | |||||
| Beneish M-Score | -2.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.2 | |||||
| 3-Year EBITDA Growth Rate | 17.6 | |||||
| 3-Year EPS without NRI Growth Rate | 17.8 | |||||
| 3-Year FCF Growth Rate | -3.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 12.72 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.53 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.08 | |||||
| 9-Day RSI | 17.33 | |||||
| 14-Day RSI | 23.12 | |||||
| 6-1 Month Momentum % | 6.45 | |||||
| 12-1 Month Momentum % | 36.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.12 | |||||
| Quick Ratio | 1 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 65.97 | |||||
| Days Sales Outstanding | 51.73 | |||||
| Days Payable | 147.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.82 | |||||
| Dividend Payout Ratio | 0.12 | |||||
| 3-Year Dividend Growth Rate | 77.4 | |||||
| Forward Dividend Yield % | 0.84 | |||||
| 5-Year Yield-on-Cost % | 1.72 | |||||
| 3-Year Average Share Buyback Ratio | 7.9 | |||||
| Shareholder Yield % | 4.57 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.85 | |||||
| Operating Margin % | 15.09 | |||||
| Net Margin % | 8.52 | |||||
| FCF Margin % | 8.45 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 10.42 | |||||
| ROIC % | 17.86 | |||||
| ROC (Joel Greenblatt) % | 31.42 | |||||
| ROCE % | 24.77 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.15 | |||||
| Forward PE Ratio | 12.86 | |||||
| PE Ratio without NRI | 14.55 | |||||
| Shiller PE Ratio | 21.63 | |||||
| Price-to-Owner-Earnings | 14.08 | |||||
| PEG Ratio | 1.02 | |||||
| PS Ratio | 1.2 | |||||
| Price-to-Free-Cash-Flow | 14.21 | |||||
| Price-to-Operating-Cash-Flow | 7.87 | |||||
| EV-to-EBIT | 11.32 | |||||
| EV-to-Forward-EBIT | 10.87 | |||||
| EV-to-EBITDA | 8.7 | |||||
| EV-to-Forward-EBITDA | 8.3 | |||||
| EV-to-Revenue | 1.75 | |||||
| EV-to-Forward-Revenue | 1.63 | |||||
| EV-to-FCF | 20.72 | |||||
| Price-to-Projected-FCF | 1.17 | |||||
| Price-to-DCF (Earnings Based) | 0.52 | |||||
| Price-to-DCF (FCF Based) | 0.55 | |||||
| Price-to-Median-PS-Value | 1.2 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.88 | |||||
| Earnings Yield (Greenblatt) % | 8.83 | |||||
| FCF Yield % | 7.37 | |||||
| Forward Rate of Return (Yacktman) % | 21.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:HCA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HCA Healthcare Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 69,621 | ||
| EPS (TTM) ($) | 22.27 | ||
| Beta | 1.51 | ||
| Volatility % | 30.35 | ||
| 14-Day RSI | 23.12 | ||
| 14-Day ATR ($) | 7.489799 | ||
| 20-Day SMA ($) | 327.5675 | ||
| 12-1 Month Momentum % | 36.63 | ||
| 52-Week Range ($) | 261.3145 - 417.14 | ||
| Shares Outstanding (Mil) | 253.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HCA Healthcare Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HCA Healthcare Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
HCA Healthcare Inc Frequently Asked Questions
What is HCA Healthcare Inc(HCA)'s stock price today?
The current price of HCA is $311.99. The 52 week high of HCA is $417.14 and 52 week low is $261.31.
When is next earnings date of HCA Healthcare Inc(HCA)?
The next earnings date of HCA Healthcare Inc(HCA) is 2025-01-30 Est..
Does HCA Healthcare Inc(HCA) pay dividends? If so, how much?
The Dividend Yield %  of HCA Healthcare Inc(HCA) is 0.82% (As of Today), Highest Dividend Payout Ratio of HCA Healthcare Inc(HCA) was 0.15. The lowest was 0.04. And the median was 0.13. The  Forward Dividend Yield % of HCA Healthcare Inc(HCA) is 0.84%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers